Modern Oral drove strong top-line growth, now comprising nearly half of total revenue, with significant gains in retail distribution and brand investment. EBITDA declined due to increased marketing spend, but full-year sales guidance was raised for Modern Oral, reflecting continued momentum.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.